In 34 Alzheimer’s patients with moderate to severe disease who took APMC for 1 year (Daily Brain Care) at 12 months showed significantly improved ADAS-cog cognition scale scores…
Interview Summary…
(Transcript summary by ChatGPT edited by Kirk Hamilton PA)
The interview features Kirk Hamilton PA in discussion with John Lewis, PhD, focusing on a novel aloe polymannose-based dietary supplement (APMC) and its potential role in improving cognition in patients with moderate to severe Alzheimer’s disease. Dr. Lewis outlines his interdisciplinary background in physiology, biostatistics, and clinical research, which positioned him to investigate complex nutritional interventions,
Continue reading An Aloe Polymannose-Based Dietary Supplement (APMC) Improves Cognition in Moderate to Severe Alzheimer’s Patients After 12 Months of Treatment…An Interview with John Lewis, PhD
